AI in Indian Healthcare: Revolution or Reality?

Healthcare artificial intelligence (AI) is increasingly viewed as a transformative force, promising enhanced diagnostics, quicker decision-making, and improved patient outcomes. In India, this potential is beginning to materialize across radiology, pathology, and public health initiatives.

India faces significant healthcare access challenges, with an estimated doctor-to-population ratio of 1:1200, falling short of the WHO’s recommended 1:1000. This disparity, based on the availability of approximately 1.38 million registered allopathic doctors for over 1.4 billion people, underscores the urgent need for innovative solutions.

Numerous healthcare AI startups are emerging, yet the divide between AI’s potential and practical implementation remains. The crucial question is whether AI can effectively bridge this gap, particularly in a country where the need is so pronounced.

The initial phase of healthcare AI focused on model development, enhancing accuracy, and demonstrating technical feasibility. According to Ankit Modi, cofounder of Qure.ai, the primary challenge now lies in deployment. Many hospitals still treat AI as an add-on, rather than integrating it into clinical workflows. The emphasis is shifting towards embedding AI natively within healthcare systems, spanning screening, diagnosis, and follow-ups.

Jadeja Dushyantsinh Anopsinh, AI advisor for eye screening startup Remidio, notes that AI efforts often miss the critical risk triaging stage, before patients consult specialists. A Remidio program in Kerala found that nearly 99% of detected diabetic retinopathy cases were previously undiagnosed, highlighting the limitations of hospital-centric AI.

Clinical applications of AI face hurdles, as medical treatments are typically administered by healthcare professionals. Kalyan Sivasailam, cofounder of radiology platform 5C Network, identifies consistent reliability in high-stakes environments as a key challenge. Companies are now developing agentic AI systems that mimic clinical reasoning to enhance reliability.

Dr. Amit Kharat, cofounder of DeepTek AI, points out that radiology remains a focal point for AI deployment due to structured imaging data and radiologist shortages. DeepTek combines infrastructure, AI integrations, and reporting workflows to expedite scan triage and report generation, easing clinician workloads.

At Qure.ai, routine diagnostics are being adapted for early detection. In Punjab, AI integration in stroke workflows has reduced turnaround times by 85%, enabling faster clinical interventions.

Despite increasing adoption, concerns persist that AI could replace clinicians. Tathagato Rai Dastidar, founder of SigTuple, clarifies that AI is transforming microscopic review in pathology, rather than replacing pathologists. AI now supports doctors across the care journey, from symptom assessment to prescription drafting, while maintaining clinician oversight.

Arjun Nagulapally, CTO at AIONOS, highlights AI’s role in coordinating healthcare processes, such as discharge planning and patient communication. These systems offer relevant insights during consultations, automate administrative tasks, and ensure patients receive clear instructions.

AI and digitization are enabling remote diagnostics, connecting smaller centers with specialist expertise and facilitating faster analysis of imaging data. AI is emerging as a valuable tool, enhancing consistency, reducing turnaround times, and extending the reach of healthcare professionals.

However, scaling AI across India’s healthcare system faces obstacles. Dastidar identifies fears of job displacement, insufficient incentives for quality, and unrealistic expectations as barriers. Ajay Mahipal of HealthKois notes that fragmented data systems and unclear governance frameworks hinder integration.

Varun Dubey, CEO of Superhealth, emphasizes that AI adoption hinges on reducing clinician friction. Governments are early adopters in public health programs, while private adoption is driven by teleradiology firms. Commercial models vary, but adoption is linked to measurable impact rather than software usage.

Surya Mantha of Capria Ventures notes that credible AI solutions operate in live clinical environments, address high-frequency problems, and continuously improve through data. Untapped areas include early screening in underserved regions and hospital operations improvements.

Sivasailam is focused on precision oncology and personalized medicine, while Dastidar aims to expand into rare diagnostic conditions where data is scarce.